CD274 and non-small cell lung carcinoma: Nicolazzo et al. reported that CTCs are detected in all NSCLC patients evaluated at 6 months after initiation of PD-1 blockade treatment, and patients harboring PD-L1-positive CTCs present a worse prognosis than those with PD-L1-negative CTC.